6183.00
-0.73%
Emkay
PSYS reported a robust operating performance in Q4. Revenue growth of 4.5% QoQ CC was in-line, while EBITM of 15.6% was ahead of our estimate. Growth was predominantly led by BFSI and Hi-Tech while HLS stood flat.
Persistent Systems has gained 26.95% in the last 3 Months
More from Persistent Systems Ltd.
Recommended